MKI67 and neuroendocrine carcinoma: Another retrospective study of patients with localized poorly differentiated NEC showed a survival advantage for patients undergoing surgery but again, Ki-67 data were not available and it is unclear if patients were appropriately classified (Thornblade et al. 2021).